1 Market Overview
    1.1 GLP-1 Therapy Definition
    1.2 Global GLP-1 Therapy Market Size and Forecast
        1.2.1 By Revenue, Global GLP-1 Therapy Market Size, 2020-2031
        1.2.2 By Sales Volume, Global GLP-1 Therapy Market Size, 2020-2031
        1.2.3 Global GLP-1 Therapy Price Trend, 2020-2031
    1.3 China GLP-1 Therapy Market Size and Forecast
        1.3.1 By Revenue, China GLP-1 Therapy Market Size, 2020-2031
        1.3.2 By Sales Volume, China GLP-1 Therapy Market Size, 2020-2031
        1.3.3 China GLP-1 Therapy Price Trend, 2020-2031
    1.4 China Percentage in Global Market
        1.4.1 By Revenue, China GLP-1 Therapy Share in Global Market, 2020-2031
        1.4.2 By Sales Volume, China GLP-1 Therapy Share in Global Market, 2020-2031
        1.4.3 GLP-1 Therapy Market Size: China VS Global, 2020-2031
    1.5 GLP-1 Therapy Market Dynamics
        1.5.1 GLP-1 Therapy Market Drivers
        1.5.2 GLP-1 Therapy Market Restraints
        1.5.3 GLP-1 Therapy Industry Trends
        1.5.4 GLP-1 Therapy Industry Policy
2 Global Competitive Landscape by Company
    2.1 Global GLP-1 Therapy Revenue by Company, 2020-2025
    2.2 Global GLP-1 Therapy Sales Volume by Company, 2020-2025
    2.3 Global GLP-1 Therapy Price by Company, 2020-2025
    2.4 Global GLP-1 Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global GLP-1 Therapy Concentration Ratio
    2.6 Global GLP-1 Therapy Mergers & Acquisitions, Expansion Plans
    2.7 Global GLP-1 Therapy Manufacturers Product Type
3 China Competitive Landscape by Company
    3.1 China GLP-1 Therapy Revenue by Company, 2020-2025
    3.2 China GLP-1 Therapy Sales Volume by Company, 2020-2025
    3.3 China GLP-1 Therapy GLP-1 Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    3.4 China GLP-1 Therapy Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
    3.5 Chinese Local Players, GLP-1 Therapy Domestic VS Export
    3.6 China Market, GLP-1 Therapy Import & Export
        3.6.1 China Market, GLP-1 Therapy Import & Export, 2020-2031
        3.6.2 China GLP-1 Therapy Import & Export Trends
        3.6.3 Main Sources of China GLP-1 Therapy Import
        3.6.4 Export Destination of China GLP-1 Therapy
4 GLP-1 Therapy Production by Region
    4.1 Global GLP-1 Therapy Capacity, Production and Capacity Utilization, 2020-2031
    4.2 Global Geographic Distribution of GLP-1 Therapy Manufacturers
    4.3 Global Major Manufacturers, GLP-1 Therapy Capacity Expansion and Future Plans
    4.4 Global GLP-1 Therapy Capacity by Region
    4.5 Global GLP-1 Therapy Production by Region
        4.5.1 Global GLP-1 Therapy Production & Forecast by Region, 2020 VS 2024 VS 2031
        4.5.2 Global GLP-1 Therapy Production by Region, 2020-2025
        4.5.3 Global GLP-1 Therapy Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
    5.1 GLP-1 Therapy Industry Chain
    5.2 GLP-1 Therapy Upstream Analysis
        5.2.1 GLP-1 Therapy Core Raw Materials
        5.2.2 Main Manufacturers of GLP-1 Therapy Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 GLP-1 Therapy Production Mode
    5.6 GLP-1 Therapy Procurement Model
    5.7 GLP-1 Therapy Industry Sales Model and Sales Channels
        5.7.1 GLP-1 Therapy Sales Model
        5.7.2 GLP-1 Therapy Typical Distributors
6 Sights by Type
    6.1 GLP-1 Therapy Classification by Type
        6.1.1 Injection
        6.1.2 Oral
    6.2 by Type, Global GLP-1 Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    6.3 by Type, Global GLP-1 Therapy Revenue, 2020-2031
    6.4 by Type, Global GLP-1 Therapy Sales Volume, 2020-2031
    6.5 by Type, Global GLP-1 Therapy Price, 2020-2031
7 Sights by Feature
    7.1 GLP-1 Therapy Classification by Feature
        7.1.1 Long-acting Drugs
        7.1.2 Short-acting Drugs
    7.2 by Feature, Global GLP-1 Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    7.3 by Feature, Global GLP-1 Therapy Revenue, 2020-2031
    7.4 by Feature, Global GLP-1 Therapy Sales Volume, 2020-2031
    7.5 by Feature, Global GLP-1 Therapy Price, 2020-2031
8 Sights by Channel
    8.1 GLP-1 Therapy Classification by Channel
        8.1.1 Online Sales
        8.1.2 Offline Sales
    8.2 by Channel, Global GLP-1 Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    8.3 by Channel, Global GLP-1 Therapy Revenue, 2020-2031
    8.4 by Channel, Global GLP-1 Therapy Sales Volume, 2020-2031
    8.5 by Channel, Global GLP-1 Therapy Price, 2020-2031
9 Sights by Application
    9.1 GLP-1 Therapy Segment by Application
        9.1.1 Type 2 Diabetes
        9.1.2 Obesity/Weight Management
        9.1.3 Other
    9.2 by Application, Global GLP-1 Therapy Market Size & CAGR, 2020 VS 2024 VS 2031
    9.3 by Application, Global GLP-1 Therapy Revenue, 2020-2031
    9.4 by Application, Global GLP-1 Therapy Sales Volume, 2020-2031
    9.5 by Application, Global GLP-1 Therapy Price, 2020-2031
10 Sales Sights by Region
    10.1 By Region, Global GLP-1 Therapy Market Size, 2020 VS 2024 VS 2031
    10.2 By Region, Global GLP-1 Therapy Revenue, 2020-2031
    10.3 By Region, Global GLP-1 Therapy Sales Volume, 2020-2031
    10.4 North America
        10.4.1 North America GLP-1 Therapy Market Size & Forecasts, 2020-2031
        10.4.2 By Country, North America GLP-1 Therapy Market Size Market Share
    10.5 Europe
        10.5.1 Europe GLP-1 Therapy Market Size & Forecasts, 2020-2031
        10.5.2 By Country, Europe GLP-1 Therapy Market Size Market Share
    10.6 Asia Pacific
        10.6.1 Asia Pacific GLP-1 Therapy Market Size & Forecasts, 2020-2031
        10.6.2 By Country/Region, Asia Pacific GLP-1 Therapy Market Size Market Share
    10.7 South America
        10.7.1 South AmericaGLP-1 Therapy Market Size & Forecasts, 2020-2031
        10.7.2 By Country, South America GLP-1 Therapy Market Size Market Share
    10.8 Middle East & Africa
11 Sales Sights by Country Level
    11.1 By Country, Global GLP-1 Therapy Market Size & CAGR，2020 VS 2024 VS 2031
    11.2 By Country, Global GLP-1 Therapy Revenue, 2020-2031
    11.3 By Country, Global GLP-1 Therapy Sales Volume, 2020-2031
    11.4 United States
        11.4.1 United States GLP-1 Therapy Market Size, 2020-2031
        11.4.2 By Company, United States GLP-1 Therapy Sales Volume Market Share, 2024
        11.4.3 by Type, United States GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.4.4 by Application, United States GLP-1 Therapy Market Size, Share, 2024 VS 2031
    11.5 Europe
        11.5.1 Europe GLP-1 Therapy Market Size, 2020-2031
        11.5.2 By Company, Europe GLP-1 Therapy Sales Volume Market Share, 2024
        11.5.3 by Type, Europe GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.5.4 by Application, Europe GLP-1 Therapy Market Size, Share, 2024 VS 2031
    11.6 China
        11.6.1 China GLP-1 Therapy Market Size, 2020-2031
        11.6.2 By Company, China GLP-1 Therapy Sales Volume Market Share, 2024
        11.6.3 by Type, China GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.6.4 by Application, China GLP-1 Therapy Market Size, Share, 2024 VS 2031
    11.7 Japan
        11.7.1 Japan GLP-1 Therapy Market Size, 2020-2031
        11.7.2 By Company, Japan GLP-1 Therapy Market Share, 2024
        11.7.3 by Type, Japan GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.7.4 by Application, Japan GLP-1 Therapy Market Size, Share, 2024 VS 2031
    11.8 South Korea
        11.8.1 South Korea GLP-1 Therapy Market Size, 2020-2031
        11.8.2 By Company, South Korea GLP-1 Therapy Market Share, 2024
        11.8.3 by Type, South Korea GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.8.4 by Application, South Korea GLP-1 Therapy Market Size, Share, 2024 VS 2031
    11.9 Southeast Asia
        11.9.1 Southeast Asia GLP-1 Therapy Market Size, 2020-2031
        11.9.2 By Company, Southeast Asia GLP-1 Therapy Market Share, 2024
        11.9.3 by Type, Southeast Asia GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.9.4 by Application, Southeast Asia GLP-1 Therapy Market Size, Share, 2024 VS 2031
    11.10 India
        11.10.1 India GLP-1 Therapy Market Size, 2020-2031
        11.10.2 By Company, India GLP-1 Therapy Market Share, 2024
        11.10.3 by Type, India GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.10.4 by Application, India GLP-1 Therapy Market Size, Share, 2024 VS 2031
    11.11 Middle East & Africa
        11.11.1 Middle East & Africa GLP-1 Therapy Market Size, 2020-2031
        11.11.2 By Company, Middle East & Africa GLP-1 Therapy Market Share, 2024
        11.11.3 by Type, Middle East & Africa GLP-1 Therapy Market Size, Share, 2024 VS 2031
        11.11.4 by Application, Middle East & Africa GLP-1 Therapy Market Size, Share, 2024 VS 2031
12 Manufacturers Profile
    12.1 Novo Nordisk
        12.1.1 Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
        12.1.2 Novo Nordisk GLP-1 Therapy Models, Specifications, and Application
        12.1.3 Novo Nordisk GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.1.4 Novo Nordisk Company Profile and Main Business
        12.1.5 Novo Nordisk Recent Developments
    12.2 Eli Lilly
        12.2.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
        12.2.2 Eli Lilly GLP-1 Therapy Models, Specifications, and Application
        12.2.3 Eli Lilly GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.2.4 Eli Lilly Company Profile and Main Business
        12.2.5 Eli Lilly Recent Developments
    12.3 Sanofi
        12.3.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
        12.3.2 Sanofi GLP-1 Therapy Models, Specifications, and Application
        12.3.3 Sanofi GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.3.4 Sanofi Company Profile and Main Business
        12.3.5 Sanofi Recent Developments
    12.4 AstraZeneca (historical)
        12.4.1 AstraZeneca (historical) Company Information, Head Office, Market Area, and Industry Position
        12.4.2 AstraZeneca (historical) GLP-1 Therapy Models, Specifications, and Application
        12.4.3 AstraZeneca (historical) GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.4.4 AstraZeneca (historical) Company Profile and Main Business
        12.4.5 AstraZeneca (historical) Recent Developments
    12.5 Teva
        12.5.1 Teva Company Information, Head Office, Market Area, and Industry Position
        12.5.2 Teva GLP-1 Therapy Models, Specifications, and Application
        12.5.3 Teva GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.5.4 Teva Company Profile and Main Business
        12.5.5 Teva Recent Developments
    12.6 Zealand Pharma
        12.6.1 Zealand Pharma Company Information, Head Office, Market Area, and Industry Position
        12.6.2 Zealand Pharma GLP-1 Therapy Models, Specifications, and Application
        12.6.3 Zealand Pharma GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.6.4 Zealand Pharma Company Profile and Main Business
        12.6.5 Zealand Pharma Recent Developments
    12.7 Pfizer
        12.7.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
        12.7.2 Pfizer GLP-1 Therapy Models, Specifications, and Application
        12.7.3 Pfizer GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.7.4 Pfizer Company Profile and Main Business
        12.7.5 Pfizer Recent Developments
    12.8 Merck (MSD)
        12.8.1 Merck (MSD) Company Information, Head Office, Market Area, and Industry Position
        12.8.2 Merck (MSD) GLP-1 Therapy Models, Specifications, and Application
        12.8.3 Merck (MSD) GLP-1 Therapy Sales Volume, Revenue, Price and Gross Margin, 2020-2025
        12.8.4 Merck (MSD) Company Profile and Main Business
        12.8.5 Merck (MSD) Recent Developments
13 Conclusion
14 Appendix
    14.1 Research Methodology
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Market Estimation Model
    14.4 Disclaimer